257 related articles for article (PubMed ID: 31941687)
21. [The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].
Lin PC; Zeng JH; Su SS; Zhou Y; Chen JJ; Chen CS; Li YP
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1050-1056. PubMed ID: 33878831
[No Abstract] [Full Text] [Related]
22. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
Chun JY; Jeong SJ; Kim S; Choi S; Lee JH; Chung HS; Park S; Lee H; Kim HY; Hwangbo B; Choi YJ
J Infect; 2024 Jun; 88(6):106159. PubMed ID: 38641139
[TBL] [Abstract][Full Text] [Related]
23. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
Fortún J; Martín-Dávila P; Gomez Garcia de la Pedrosa E; Silva JT; Garcia-Rodríguez J; Benito D; Venanzi E; Castaño F; Fernández-Ruiz M; Lazaro F; García-Luján R; Quiles I; Cabanillas JJ; Moreno S; Aguado JM
J Infect; 2016 Jun; 72(6):738-744. PubMed ID: 27025205
[TBL] [Abstract][Full Text] [Related]
24. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.
Kono Y; Tsushima K; Yamaguchi K; Kurita N; Soeda S; Fujiwara A; Sugiyama S; Togashi Y; Kasagi S; To M; To Y; Setoguchi Y
Respir Med; 2013 Jul; 107(7):1094-100. PubMed ID: 23632100
[TBL] [Abstract][Full Text] [Related]
25. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
26. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
Bergeron A; Belle A; Sulahian A; Lacroix C; Chevret S; Raffoux E; Arnulf B; Socié G; Ribaud P; Tazi A
Chest; 2010 Feb; 137(2):410-5. PubMed ID: 19801584
[TBL] [Abstract][Full Text] [Related]
27. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
[TBL] [Abstract][Full Text] [Related]
28. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.
Lu Y; Liu L; Li H; Chen B; Gu Y; Wang L; Feng C; Chen C; Chen Y; Sun W; Cui X; Cao M; Tao Y; Zhong J; Zhong H; Ni Y; Cai Y; Song M; Liu X; Shi Y; Su X
Clin Microbiol Infect; 2023 Jun; 29(6):797.e1-797.e7. PubMed ID: 36773771
[TBL] [Abstract][Full Text] [Related]
29. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
[TBL] [Abstract][Full Text] [Related]
30. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
32. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
[TBL] [Abstract][Full Text] [Related]
33. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
Nguyen MH; Jaber R; Leather HL; Wingard JR; Staley B; Wheat LJ; Cline CL; Baz M; Rand KH; Clancy CJ
J Clin Microbiol; 2007 Sep; 45(9):2787-92. PubMed ID: 17596367
[TBL] [Abstract][Full Text] [Related]
34. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
[TBL] [Abstract][Full Text] [Related]
35. Systematic review and meta-analysis of galactomannan antigen testing in serum and bronchoalveolar lavage for the diagnosis of chronic pulmonary aspergillosis: defining a cutoff.
de Oliveira VF; Silva GD; Taborda M; Levin AS; Magri MMC
Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1047-1054. PubMed ID: 37430166
[TBL] [Abstract][Full Text] [Related]
36. The Utility of Galactomannan and Polymerase Chain Reaction Assays in Bronchoalveolar Lavage for Diagnosis of Chronic Pulmonary Aspergillosis.
Chowdhury M; Singh G; Pandey M; Mishra H; Meena VP; Sethi P; Singh A; Prakash B; Upadhyay AD; Mohan A; Sinha S; Xess I; Wig N; Kabra SK; Ray A
Mycopathologia; 2023 Dec; 188(6):1041-1053. PubMed ID: 37857979
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.
Torelli R; Sanguinetti M; Moody A; Pagano L; Caira M; De Carolis E; Fuso L; De Pascale G; Bello G; Antonelli M; Fadda G; Posteraro B
J Clin Microbiol; 2011 Dec; 49(12):4273-8. PubMed ID: 22012015
[TBL] [Abstract][Full Text] [Related]
38. False positive bronchoalveolar lavage galactomannan: Effect of host and cut-off value.
Farmakiotis D; Le A; Weiss Z; Ismail N; Kubiak DW; Koo S
Mycoses; 2019 Mar; 62(3):204-213. PubMed ID: 30387195
[TBL] [Abstract][Full Text] [Related]
39. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
Taghizadeh-Armaki M; Hedayati MT; Moqarabzadeh V; Ansari S; Mahdavi Omran S; Zarrinfar H; Saber S; Verweij PE; Denning DW; Seyedmousavi S
J Med Microbiol; 2017 Jul; 66(7):898-904. PubMed ID: 28693685
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the diagnostic accuracy of galactomannan from the bronchoalveolar lavage fluid of patients with suspected invasive pulmonary aspergillosis.
Bernardi RM; Holler SR; Almeida EGC; Anton C; Machado FD; Silva DR
Rev Iberoam Micol; 2022; 39(2):31-35. PubMed ID: 35461766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
